Cell therapy market size | Growth Insights & Forecast 2025

What is the Cell Therapy Market Size?

This growth is driven by rising demand for regenerative therapies, advancements in stem cell research, and increasing investment in personalized treatments.

Key Growth Drivers in the Cell Therapy Market

• Rising prevalence of chronic and degenerative diseases, especially cancer.
• Advancements in stem cell research and regenerative medicine.
• Supportive regulatory frameworks and faster clinical approvals.
• Growing investments in personalized and precision therapies.
• Expansion of cell therapy manufacturing infrastructure and logistics.
• Collaborations between academic institutions and biotech firms for R&D.

Cell Therapy Market Trends

Cell Therapy Market is expected to be shaped by several key trends, including the rapid expansion of CAR-T and TCR-based treatments in oncology, alongside significant advancements in stem cell platforms such as autologous and allogeneic formats. It is also becoming more efficient by technological advancements in cell processing, cryopreservation, and mass manufacture processes. What is more, there is growing cooperation between biotechnology companies and academia which is creating a faster development of the pipeline and innovation in all therapeutic areas.

Major Companies in the Cell therapy market

• Novartis
• Gilead Sciences
• Johnson & Johnson
• Bristol Myers Squibb
• Thermo Fisher Scientific
• Lonza
• WuXi AppTec

Frequently Asked Questions About the Market Study (FAQs)